Add to ORKGHeadache is the most common symptom of IIH. The IIHTT prospectively enrolled 165 participants with mild visual field loss to assess whether acetazolamide (ACZ) plus dietary management was superior to placebo (PBO) tablets plus dietary management in improving visual function [1]. We report the headache outcomes of participants in the IIHTT
Headache is a common symptom when patients initially develop idiopathic intracranial hypertension (I...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Headache is the most common symptom of IIH. The IIHTT prospectively enrolled 165 participants with m...
The Neuro-Ophthalmology Research Disease Consortium (NORDIC) has developed the IIHTT. This trial, fu...
The purpose of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) was to determine whe...
OBJECTIVE Headache is a near-universal sequela of idiopathic intracranial hypertension (IIH). The...
Treatment of idiopathic intracranial hypertension (IIH) is based on anecdotal uncontrolled data as t...
The management of idiopathic intracranial hypertension (IIH) remains controversial. The Idiopathic I...
Our goal was to determine whether the beneficial effects of acetazolamide (ACZ) in improving vision ...
To determine the prevalence of visual field (VF) performance failures (PF) and treatment failures (T...
Background: Headache is the most common symptom of idiopathic intracranial hypertension (IIH) and ma...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
To examine the tolerability and adverse events reported in the Idiopathic Intracranial Hypertension ...
Headache is a common symptom when patients initially develop idiopathic intracranial hypertension (I...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Headache is the most common symptom of IIH. The IIHTT prospectively enrolled 165 participants with m...
The Neuro-Ophthalmology Research Disease Consortium (NORDIC) has developed the IIHTT. This trial, fu...
The purpose of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) was to determine whe...
OBJECTIVE Headache is a near-universal sequela of idiopathic intracranial hypertension (IIH). The...
Treatment of idiopathic intracranial hypertension (IIH) is based on anecdotal uncontrolled data as t...
The management of idiopathic intracranial hypertension (IIH) remains controversial. The Idiopathic I...
Our goal was to determine whether the beneficial effects of acetazolamide (ACZ) in improving vision ...
To determine the prevalence of visual field (VF) performance failures (PF) and treatment failures (T...
Background: Headache is the most common symptom of idiopathic intracranial hypertension (IIH) and ma...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
To examine the tolerability and adverse events reported in the Idiopathic Intracranial Hypertension ...
Headache is a common symptom when patients initially develop idiopathic intracranial hypertension (I...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...